172@29@17@249!~!172@29@0@53!~!|news|venusremedies|management-interviews-VR01-6months.html!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
Moneycontrol
you are here: HomeNewsVenusremedies
management interviews
Jump to
3 Results Found
  • Venus Remedies receives nod from Saudi Arabia for Meropenem Dec 06, 2013 03:48 PM IST

    Venus Remedies receives nod from Saudi Arabia for Meropenem

    Dheeraj Aggarwal, CFO, Venus Remedies is especially ecstatic about bagging the marketing rights for Meropenem in Gulf, Saudi Arabia as the company would be the first generic player there.

  • Venus Remedies signs out-licensing pact; stock up 20% May 08, 2013 04:47 PM IST

    Venus Remedies signs out-licensing pact; stock up 20%

    Venus Remedies entered OTC (over-the-counter) category with Ezenus. Dheeraj Aggarwal, CFO, Venus Remedies says that Ezenus is our first OTC product which is a stress reliever. It works for reducing anti-toxicants in the body.

  • New OTC drug to garner Rs 25cr revenues: Venus Remedies Mar 25, 2013 04:14 PM IST

    New OTC drug to garner Rs 25cr revenues: Venus Remedies

    Dheeraj Aggarwal, CFO, Venus Remedies, speaking to CNBC-TV18 on the occasion of the company's first ever over-the-counter (OTC) stress reliving drug launch, said that it is a unique product with no competition.

Sections